Showing 1–16 of 271 results
-
ACTEMRA (tocilizumab) injection, for intravenous or subcutaneous use
Read more -
ADAKVEO (crizanlizumab-tmca) injection, for intravenous use. Initial U.S. Approval: 2019
Read more -
AGAMREE (vamorolone)
Read more -
AKEEGA (niraparib and abiraterone acetate) tablets
Read more -
ALIQOPA (copanlisib) for injection, for intravenous use.
Read more -
AMVUTTRA (vutrisiran) injection
Read more -
ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo). Lyophilized powder for solution for intravenous injection.
Read more -
ANKTIVA (nogapendekin alfa inbakicept-pmln) solution
Read more -
APHEXDA (motixafortide)
Read more -
Atriance (nelarabine) for injection
Read more -
AUGTYRO (repotrectinib) capsules
Read more -
AVASTIN (bevacizumab) Solution for intravenous infusion. Initial U.S. Approval: 2004
Read more -
AVSOLA (infliximab-axxq) for injection, for intravenous use.
Read more -
AYVAKIT (avapritinib) tablets, for oral use. Initial U.S. Approval: 2020
Read more -
BALVERSA (erdafitinib) tablets
Read more -
Bevacizumab Injection. Initial U.S. Approval: 2004
Read more
